Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease
The primary objectives of this study are to evaluate the safety and tolerability of the pneumococcal 21 valent conjugate vaccine (V116), and to evaluate the serotype-specific opsonophagocytic activity (OPA) post-vaccination with